Legal & General Group Plc Reduces ResMed Inc. Stake

The institutional investor sold 13,257 shares of the medical equipment provider in the third quarter.

Mar. 12, 2026 at 10:52am

Got story updates? Submit your updates here. ›

Legal & General Group Plc, a major institutional investor, reduced its holdings in ResMed Inc. (NYSE:RMD) by 1.4% during the third quarter. The firm now owns 958,210 shares of the medical equipment provider's stock, valued at $262,291,000 as of its most recent SEC filing.

Why it matters

ResMed is a leading global provider of medical devices and cloud-connected solutions for sleep apnea and other respiratory conditions. Changes in institutional ownership of the company's stock can provide insights into market sentiment and potential shifts in the company's performance.

The details

According to the report, Legal & General Group Plc sold 13,257 shares of ResMed during the third quarter, reducing its total stake in the company. The firm now owns 958,210 shares, worth approximately $262.3 million. The sale represents a 1.4% decrease in Legal & General's ResMed holdings.

  • The share sale occurred during the third quarter of the year.

The players

Legal & General Group Plc

A major institutional investor that reduced its holdings in ResMed Inc.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Legal & General Group Plc's ResMed holdings suggests a potential shift in market sentiment or portfolio rebalancing by the institutional investor. However, without additional context, it's difficult to determine the specific reasons behind the sale or its broader implications for ResMed's business and stock performance.